| Current status of autologous stem cell transplantation for multiple myeloma R Al Hamed, AH Bazarbachi, F Malard, JL Harousseau, M Mohty Blood cancer journal 9 (4), 44, 2019 | 246 | 2019 |
| Relapsed refractory multiple myeloma: a comprehensive overview AH Bazarbachi, R Al Hamed, F Malard, JL Harousseau, M Mohty Leukemia 33 (10), 2343-2357, 2019 | 140 | 2019 |
| Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from … R Al Hamed, AH Bazarbachi, M Mohty Bone marrow transplantation 55 (1), 25-39, 2020 | 117 | 2020 |
| Comprehensive review of AL amyloidosis: some practical recommendations R Al Hamed, AH Bazarbachi, A Bazarbachi, F Malard, JL Harousseau, ... Blood Cancer Journal 11 (5), 97, 2021 | 64 | 2021 |
| Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies R Mohty, R Dulery, AH Bazarbachi, M Savani, RA Hamed, A Bazarbachi, ... Blood Cancer Journal 11 (7), 126, 2021 | 38 | 2021 |
| Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update AH Bazarbachi, R Al Hamed, F Malard, A Bazarbachi, JL Harousseau, ... Blood Cancer Journal 12 (3), 47, 2022 | 35 | 2022 |
| Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant AH Bazarbachi, R Al Hamed, F Malard, M Mohty, A Bazarbachi Therapeutic Advances in Hematology 10, 2040620719882666, 2019 | 30 | 2019 |
| Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute … AH Bazarbachi, R Al Hamed, M Labopin, B Afanasyev, RM Hamladji, ... Bone marrow transplantation 55 (3), 595-602, 2020 | 25 | 2020 |
| Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J 9: 44 R Al Hamed, AH Bazarbachi, F Malard, JL Harousseau, M Mohty | 14* | 2019 |
| Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from … AH Bazarbachi, R Al Hamed, M Labopin, K Halaburda, H Labussiere, ... Bone marrow transplantation 56 (4), 917-927, 2021 | 13 | 2021 |
| Cytomegalovirus events in high‐risk allogeneic hematopoietic‐cell transplantation patients who received letermovir prophylaxis K Chen, E Arbona‐Haddad, MP Cheng, AM McDonnell, M Gooptu, ... Transplant Infectious Disease 23 (4), e13619, 2021 | 9 | 2021 |
| Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease R Mohty, R Al Hamed, A Bazarbachi, E Brissot, A Nagler, A Zeidan, ... Journal of Hematology & Oncology 15 (1), 124, 2022 | 8 | 2022 |
| Outcome of stem cell transplantation in HTLV-1-associated north American adult T-cell leukemia/lymphoma AH Bazarbachi, D Reef, H Narvel, R Patel, R Al Hamed, S Vikash, ... Clinical hematology international 5 (2), 78-91, 2023 | 6 | 2023 |
| Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated … R Al Hamed, M Labopin, E Daguindau, R Niittyvuopio, A Huynh, G Socié, ... Cancer medicine 11 (4), 1068-1080, 2022 | 5 | 2022 |
| Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia—Improved outcomes over time: A European … R Al Hamed, M Ngoya, JE Galimard, H Sengeloev, T Gedde‐Dahl, ... Cancer 129 (17), 2645-2654, 2023 | 3 | 2023 |
| Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT R Al Hamed, M Labopin, D Wu, T Gedde-Dahl, M Aljurf, E Forcade, ... Bone marrow transplantation, 1-8, 2024 | | 2024 |
| TBI-BASED VERSUS CHEMOTHERAPY-BASED AMSA/ARA-C CONDITIONING REGIMENS IN PRIMARY REFRACTORY AML SIGNIFICANTLY WORSE OUTCOMES IN YOUNGER PATIENTS CONDITIONED WITH TBI R Al Hamed, M Labopin, W Bethge, A Gangser, A Brecht, J Tischer, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 349-350, 2023 | | 2023 |
| Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis. S Vikash, F Vikash, A Mehta, F Bteich, R Al Hamed, K Neupane, ... Journal of Clinical Oncology 41 (16_suppl), e16079-e16079, 2023 | | 2023 |
| Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma K Neupane, R Dahal, AH Bazarbachi, DK Reef, R Al Hamed, K Pradhan, ... Journal of Clinical Oncology 41 (16_suppl), e18557-e18557, 2023 | | 2023 |
| Web-based patient educational material on chimeric antigen receptor T-cell therapy: Quantitative assessment of readability. RK Thakur, A Adhikari, K Neupane, MBB Hammami, CTR Vegivinti, ... Journal of Clinical Oncology 41 (16_suppl), 11040-11040, 2023 | | 2023 |
